A detailed history of Ameritas Investment Partners, Inc. transactions in Pulmonx Corp stock. As of the latest transaction made, Ameritas Investment Partners, Inc. holds 3,617 shares of LUNG stock, worth $22,931. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,617
Previous 3,617 -0.0%
Holding current value
$22,931
Previous $22,000 31.82%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

BUY
$9.88 - $14.0 $10,393 - $14,728
1,052 Added 41.01%
3,617 $37,000
Q2 2022

Aug 12, 2022

BUY
$14.0 - $27.95 $8,036 - $16,043
574 Added 28.83%
2,565 $37,000
Q2 2021

Aug 06, 2021

BUY
$37.61 - $48.0 $38,286 - $48,864
1,018 Added 104.62%
1,991 $88,000
Q4 2020

Feb 12, 2021

BUY
$39.31 - $69.02 $38,248 - $67,156
973 New
973 $67,000

Others Institutions Holding LUNG

About Pulmonx Corp


  • Ticker LUNG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,268,400
  • Market Cap $236M
  • Description
  • Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...
More about LUNG
Track This Portfolio

Track Ameritas Investment Partners, Inc. Portfolio

Follow Ameritas Investment Partners, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameritas Investment Partners, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ameritas Investment Partners, Inc. with notifications on news.